Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Review

Multicenter Study

Comparative Study

Meta-Analysis

Systematic Review

Research Support, N.I.H., Intramural

Comment

Letter

Clinical Trial, Phase IV

Network Meta-Analysis

Clinical Trial

Controlled Clinical Trial

Editorial

Publication Year

From

Quick links

Individual year

2025

2024

2023

2022

2021

2018

2017

2016

2015

2014

2013

2012

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Vortioxetine""[mesh_terms]

48 Results

Searching titles within these results

Vortioxetine: A multimodal antidepressant or another selective serotonin reuptake inhibitor?

Judy Hope, Christine Culhane, Nicholas A Keks

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 2016;23(3):210-3

Full Text

Abstract

Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review.

Adrián Neyra, Javier De Diego-Adeliño, José Manuel Crespo, Fernando Mora, Pedro Iborra, Luis Gutiérrez-Rojas, Selman F Salonia

Expert opinion on drug safety 2022;21(5):673-690

Free Full Text

Abstract

New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine.

Michele Fornaro, Domenico De Berardis, Massimo Di Giannantonio, Giovanni Martinotti, Andrea de Bartolomeis, Giampaolo Perna, Roberta Vecchiotti, Monica Mazza, Annastasia Fiengo, Federica Vellante, Elisabetta Filomena Buonaguro, Felice Iasevoli, Alessandro Valchera, Carmine Tomasetti, Laura Orsolini

Expert review of neurotherapeutics 2017;16(5):483-95

Full Text

Abstract

Risks Associated with Vortioxetine in the Established Therapeutic Indication.

Akansha Verma, Anoop Kumar

Current neuropharmacology 2021;19(5):711-717

Free Full Text

Abstract

Vortioxetine in management of major depressive disorder - a favorable alternative for elderly patients?

Dorota Danielak

Expert opinion on pharmacotherapy 2021;22(9):1167-1177

Full Text

Abstract

Influence of Crystal Disorder on the Forced Oxidative Degradation of Vortioxetine HBr.

Dattatray Modhave, Brenda Barrios, Jayant Iyer, Amrit Paudel

AAPS PharmSciTech 2024;25(1):10

Full Text

Abstract

A comparison of real-world effectiveness of vortioxetine along the treatment algorithm for major depressive disorder.

Rohini Bose, Syed Usman Hamdani, Fareed Aslam Minhas, Keira Joann Herr

Current medical research and opinion 2022;38(5):661-671

Full Text

Abstract

Effectiveness of vortioxetine in patients with major depressive disorder and early-stage dementia: The MEMORY study.

Michael Cronquist Christensen, Simon Nitschky Schmidt, Iria Grande

Journal of affective disorders 2023;338():423-431

Free Full Text

Abstract

Safety and efficacy of vortioxetine on depressive symptoms and cognition in post-stroke patients: a pilot study.

G Gamberini, F G Masuccio, G Ferriero, D Cattaneo, C Solaro

Journal of affective disorders 2021;286():108-109

Full Text

Vortioxetine versus Duloxetine in the Treatment of Patients with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials.

Guangjian Li, Xu Wang, Dihui Ma

Clinical drug investigation 2016;36(7):509-17

Full Text

Abstract

Pharmacotherapy of major depression in late life: what is the role of new agents?

Kinjal Patel, Tarek K Rajji, Benoit H Mulsant, Petal S Abdool

Expert opinion on pharmacotherapy 2017;18(6):599-609

Full Text

Abstract

A Taiwanese study on real-world evidence with vortioxetine in patients with major depression in Asia (TREVIDA).

Yen Kuang Yang, Cheng-Sheng Chen, Chia-Fen Tsai, Chia-Ming Chang, Te-Jen Lai, Chun-Te Lee, Chih-Chien Lin, Tsuo-Hung Lan, Keira Joann Herr

Current medical research and opinion 2022;37(12):2163-2173

Full Text

Abstract

Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.

Gernot Wagner, Marie-Therese Schultes, Viktoria Titscher, Birgit Teufer, Irma Klerings, Gerald Gartlehner

Journal of affective disorders 2018;228():1-12

Full Text

Abstract

Effect of Vortioxetine on Cognitive Impairment in Patients With Major Depressive Disorder: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

I-Chen Huang, Tsui-San Chang, Chiehfeng Chen, Jia-Ying Sung

The international journal of neuropsychopharmacology 2022;25(12):969-978

Free Full Text

Abstract

Development of the Validated Stability-Indicating Method for the Determination of Vortioxetine in Bulk and Pharmaceutical Formulation by HPLC-DAD, Stress Degradation Kinetics Studies and Detection of Degradation Products by LC-ESI-QTOF-MS.

Karol Wróblewski, Małgorzata Szultka-Młyńska, Daria Janiszewska, Anna Petruczynik, Bogusław Buszewski

Molecules (Basel, Switzerland) 2022;27(6):1883

Free Full Text

Abstract

Results: 1 – 15 / 48

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Vortioxetine""[mesh_terms]

Vortioxetine: A multimodal antidepressant or another selective serotonin reuptake inhibitor?

Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review.

New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine.

Risks Associated with Vortioxetine in the Established Therapeutic Indication.

Vortioxetine in management of major depressive disorder - a favorable alternative for elderly patients?

Influence of Crystal Disorder on the Forced Oxidative Degradation of Vortioxetine HBr.

A comparison of real-world effectiveness of vortioxetine along the treatment algorithm for major depressive disorder.

Effectiveness of vortioxetine in patients with major depressive disorder and early-stage dementia: The MEMORY study.

Safety and efficacy of vortioxetine on depressive symptoms and cognition in post-stroke patients: a pilot study.

Vortioxetine versus Duloxetine in the Treatment of Patients with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials.

Pharmacotherapy of major depression in late life: what is the role of new agents?

A Taiwanese study on real-world evidence with vortioxetine in patients with major depression in Asia (TREVIDA).

Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.

Effect of Vortioxetine on Cognitive Impairment in Patients With Major Depressive Disorder: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Development of the Validated Stability-Indicating Method for the Determination of Vortioxetine in Bulk and Pharmaceutical Formulation by HPLC-DAD, Stress Degradation Kinetics Studies and Detection of Degradation Products by LC-ESI-QTOF-MS.

Results for
""Vortioxetine""[mesh_terms]